Maha Katabi

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Joseph R. Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maha Katabi:

Form 4 holding Director, 10%+ Owner

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
$204,625
Report date
05 Jun 2024
Price
$16.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RayzeBio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
26 Feb 2024
Price
$62.50
Ownership
Indirect
Form 4 holding Director

RayzeBio, Inc.

Security class
Series D Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
19 Sep 2023
Price
Ownership
By Sofinnova Venture Partners XI, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RayzeBio, Inc.

Security class
Series D Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
19 Sep 2023
Price
Ownership
By Sofinnova Venture Partners X, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RayzeBio, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
26 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Maha Katabi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .